Indications: Type 2 diabetes, CV risk reduction in T2D patients with heart disease Doses: 0.6 mg (starter) 1.2 mg 1.8 mg/day Best for: Patients wanting a daily injectable with strong CV data Rybelsus (Oral Semaglutide Tablet) Rybelsus is the only oral GLP-1 medication currently available
However, this slower digestion is also the primary reason for symptoms like nausea, bloating, and changes in bowel habits that people experience
Market Competition and M&A The obesity markets deal-making frenzy shows no signs of slowing
Proc Natl Acad Sci USA 104:1662116626 Han J, Cheng FC, Yang Z, Dryhurst G (1999) Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinsons disease
In the last 5 years Agnieszka Jakubowska conducts trials funded by: Eli Lilly, NewAmsterdam, and Novo Nordisk